254 related articles for article (PubMed ID: 16617107)
1. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans.
Cheng K; Wu TJ; Wu KK; Sturino C; Metters K; Gottesdiener K; Wright SD; Wang Z; O'Neill G; Lai E; Waters MG
Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6682-7. PubMed ID: 16617107
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
3. Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats.
Almishri W; Cossette C; Rokach J; Martin JG; Hamid Q; Powell WS
J Pharmacol Exp Ther; 2005 Apr; 313(1):64-9. PubMed ID: 15590767
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus.
Zhang S; Wu X; Yu S
Dis Esophagus; 2014 Aug; 27(6):601-6. PubMed ID: 24165271
[TBL] [Abstract][Full Text] [Related]
5. Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1.
Lai E; De Lepeleire I; Crumley TM; Liu F; Wenning LA; Michiels N; Vets E; O'Neill G; Wagner JA; Gottesdiener K
Clin Pharmacol Ther; 2007 Jun; 81(6):849-57. PubMed ID: 17392721
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pro-adipogenic effects between prostaglandin (PG) D
Rahman MS; Syeda PK; Nartey MNN; Chowdhury MMI; Shimizu H; Nishimura K; Jisaka M; Shono F; Yokota K
Prostaglandins Other Lipid Mediat; 2018 Nov; 139():71-79. PubMed ID: 30393164
[TBL] [Abstract][Full Text] [Related]
7. DP1 receptor agonist, BW245C inhibits diet-induced obesity in ApoE
Kumar S; Palaia T; Hall C; Ragolia L
Obes Res Clin Pract; 2018; 12(2):229-241. PubMed ID: 28602634
[TBL] [Abstract][Full Text] [Related]
8. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils.
Cossette C; Walsh SE; Kim S; Lee GJ; Lawson JA; Bellone S; Rokach J; Powell WS
J Pharmacol Exp Ther; 2007 Jan; 320(1):173-9. PubMed ID: 17041009
[TBL] [Abstract][Full Text] [Related]
9. CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine.
Prenn C; Heinemann A; Schuligoi R; Peskar BA
Pharmacology; 2008; 81(3):236-40. PubMed ID: 18212515
[TBL] [Abstract][Full Text] [Related]
10. Effect of PGD
Sekeroglu A; Jacobsen JM; Jansen-Olesen I; Gupta S; Sheykhzade M; Olesen J; Bhatt DK
Pharmacol Rep; 2017 Feb; 69(1):50-56. PubMed ID: 27898338
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor.
Monneret G; Gravel S; Diamond M; Rokach J; Powell WS
Blood; 2001 Sep; 98(6):1942-8. PubMed ID: 11535533
[TBL] [Abstract][Full Text] [Related]
12. Expression of DP2 (CRTh2), a prostaglandin D₂ receptor, in human mast cells.
Moon TC; Campos-Alberto E; Yoshimura T; Bredo G; Rieger AM; Puttagunta L; Barreda DR; Befus AD; Cameron L
PLoS One; 2014; 9(9):e108595. PubMed ID: 25268140
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
Xue L; Gyles SL; Wettey FR; Gazi L; Townsend E; Hunter MG; Pettipher R
J Immunol; 2005 Nov; 175(10):6531-6. PubMed ID: 16272307
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin D
Carstensen S; Gress C; Erpenbeck VJ; Kazani SD; Hohlfeld JM; Sandham DA; Müller M
Respir Res; 2021 Oct; 22(1):262. PubMed ID: 34620168
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin D2 mediates neuronal protection via the DP1 receptor.
Liang X; Wu L; Hand T; Andreasson K
J Neurochem; 2005 Feb; 92(3):477-86. PubMed ID: 15659218
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin D2 and the role of the DP1, DP2 and TP receptors in the control of airway reflex events.
Maher SA; Birrell MA; Adcock JJ; Wortley MA; Dubuis ED; Bonvini SJ; Grace MS; Belvisi MG
Eur Respir J; 2015 Apr; 45(4):1108-18. PubMed ID: 25323233
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin D2 regulates joint inflammation and destruction in murine collagen-induced arthritis.
Maicas N; Ibáñez L; Alcaraz MJ; Úbeda A; Ferrándiz ML
Arthritis Rheum; 2012 Jan; 64(1):130-40. PubMed ID: 21898357
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2.
Zayed N; Afif H; Chabane N; Mfuna-Endam L; Benderdour M; Martel-Pelletier J; Pelletier JP; Motiani RK; Trebak M; Duval N; Fahmi H
Arthritis Rheum; 2008 Nov; 58(11):3530-40. PubMed ID: 18975308
[TBL] [Abstract][Full Text] [Related]
19. PGD2 DP1 receptor stimulation following stroke ameliorates cerebral blood flow and outcomes.
Ahmad AS
Neuroscience; 2014 Oct; 279():260-8. PubMed ID: 25218962
[TBL] [Abstract][Full Text] [Related]
20. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.
Monneret G; Cossette C; Gravel S; Rokach J; Powell WS
J Pharmacol Exp Ther; 2003 Jan; 304(1):349-55. PubMed ID: 12490611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
